REGULATION OF SGLT-2 BY THE SYMPATHETIC NERVOUS SYSTEM

被引:0
|
作者
Schlaich, Markus [1 ]
Elliott, Rosemary [1 ]
Rudnicka, Caroline [1 ]
Matthews, Vance [1 ]
机构
[1] Univ Western Australia, Dobney Hypertens Ctr, Nedlands, WA, Australia
关键词
D O I
10.1097/01.hjh.0000501008.46096.cd
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
OS 33-04
引用
收藏
页码:E394 / E394
页数:1
相关论文
共 50 条
  • [31] The sympathetic nervous system in white adipose tissue regulation
    Rayner, DV
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) : 357 - 364
  • [32] Regulation of leptin production: sympathetic nervous system interactions
    Rayner, DV
    Trayhurn, P
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (01): : 8 - 20
  • [33] REGULATION OF CATECHOLAMINE METABOLISM IN SYMPATHETIC NERVOUS-SYSTEM
    VONEULER, US
    PHARMACOLOGICAL REVIEWS, 1972, 24 (02) : 365 - &
  • [34] SYMPATHETIC NERVOUS SYSTEM REGULATION OF SALIVARY GLAND GROWTH
    WELLS, H
    HANDELMAN, CS
    JOURNAL OF DENTAL RESEARCH, 1961, 40 (04) : 740 - &
  • [35] REGULATION OF SYMPATHETIC NERVOUS-SYSTEM (SNS) BY DIET
    YOUNG, JB
    LANDSBERG, L
    CLINICAL RESEARCH, 1977, 25 (05): : A666 - A666
  • [36] Regulation of leptin production: sympathetic nervous system interactions
    D. Vernon Rayner
    Paul Trayhurn
    Journal of Molecular Medicine, 2001, 79 : 8 - 20
  • [37] A novel SGLT-2 score to identify HFpEF patients who may benefit from SGLT-2 inhibitors
    Binder, C.
    Poglitsch, M.
    Retil, R. R.
    Dachs, T.
    Seirer, B.
    Capelle, C.
    Dusik, F.
    Duca, F.
    Dalos, D.
    Schrutka, L.
    Badr-Eslam, R.
    Bonderman, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1141 - 1141
  • [38] The regulation of sympathetic nervous system development by the bHLH factor Hand2
    Morikawa, Yuka
    D'Autreaux, Fabien
    Gershon, Michael D.
    Cserjesi, Peter
    DEVELOPMENTAL BIOLOGY, 2007, 306 (01) : 295 - 295
  • [39] SGLT-2 Inhibitors and Regenerative Cell Exhaustion
    Hess, David A.
    Terenzi, Daniella C.
    Verma, Subodh
    CELL METABOLISM, 2020, 31 (05) : 884 - 885
  • [40] Adverse effects and safety of SGLT-2 inhibitors
    Halimi, S.
    Verges, B.
    DIABETES & METABOLISM, 2014, 40 : S28 - S34